Mayport LLC’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$924K Buy
1,005
+38
+4% +$38.5K 0.17% 49
2025
Q4
$1.04M Buy
967
+17
+2% +$16.3K 0.21% 43
2025
Q3
$725K Buy
950
+51
+6% +$38K 0.16% 45
2025
Q2
$700K Buy
899
+7
+0.8% +$5.44K 0.17% 47
2025
Q1
$737K Buy
892
+279
+46% +$232K 0.2% 41
2024
Q4
$473K Buy
613
+4
+0.7% +$3.31K 0.14% 52
2024
Q3
$540K Hold
609
0.17% 45
2024
Q2
$551K Hold
609
0.2% 46
2024
Q1
$474K Hold
609
0.18% 50
2023
Q4
$355K Hold
609
0.16% 61
2023
Q3
$327K Hold
609
0.18% 50
2023
Q2
$286K Hold
609
0.16% 56
2023
Q1
$209K Hold
609
0.13% 64
2022
Q4
$223K Buy
+609
New +$216K 0.17% 52

Other funds holding LLY

Mayport LLC's LLY Position: Q1 2026 in Review

Mayport LLC increased its Eli Lilly (LLY) stake by 3.9% in Q1 2026, buying an estimated $38.5K and bringing the position to 1,005 shares worth $924K. The position accounts for 0.17% of the portfolio, ranked #49.

Mayport LLC first reported a position in LLY in Q4 2022 and has held it in 14 quarters since. The position peaked at $1.04M in Q4 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Mayport LLC held 1,005 shares of Eli Lilly worth $924K as of Q1 2026.
  • Mayport LLC bought 38 Eli Lilly shares in Q1 2026, an estimated $38.5K.
  • Eli Lilly made up 0.17% of Mayport LLC's portfolio in Q1 2026, its #49 holding.
  • Mayport LLC first reported a position in Eli Lilly in Q4 2022 and has held it in 14 quarters since.
  • Mayport LLC's Eli Lilly position peaked at $1.04M in Q4 2025.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Mayport LLC's 13F filing for Q1 2026, filed 21 Apr 2026.